In today’s news reports we note new articles dealing with:
- Biopsy protocols, patient selection, and focal therapy
- Tertiary Gleason pattern 4/5 and risk for progression post-RP
- Evolving data on the uses of bisphosphonates and denosumab
- SKIs in treatment of advanced forms of prostate cancer … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: bisphosphonate, dasatinib, denosumab, focal therapy, Gleason, saracatinib, tertiary, zoledronate | 7 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 